PA8537101A1 - Antagonistas de receptores de histamina - Google Patents

Antagonistas de receptores de histamina

Info

Publication number
PA8537101A1
PA8537101A1 PA20028537101A PA8537101A PA8537101A1 PA 8537101 A1 PA8537101 A1 PA 8537101A1 PA 20028537101 A PA20028537101 A PA 20028537101A PA 8537101 A PA8537101 A PA 8537101A PA 8537101 A1 PA8537101 A1 PA 8537101A1
Authority
PA
Panama
Prior art keywords
histamine
histamine receiver
receiver antagonists
antagonist
antagonists
Prior art date
Application number
PA20028537101A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8537101A1 publication Critical patent/PA8537101A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTA INVENCION PROPORCIONA UNA COMBINACION DE (a) UN ANTAGONISTA DE RECEPTOR H1 DE HISTAMINA Y (b) UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR F4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMNA; Y UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR H4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMINA; Y SUS COMPOSICIONES Y USOS.
PA20028537101A 2001-01-17 2002-01-14 Antagonistas de receptores de histamina PA8537101A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
PA8537101A1 true PA8537101A1 (es) 2002-08-29

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20028537101A PA8537101A1 (es) 2001-01-17 2002-01-14 Antagonistas de receptores de histamina

Country Status (31)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223L (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
JP2006510590A (ja) * 2002-09-06 2006-03-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アレルギー及び喘息の処置のためのヒスタミンｈ４受容体モジュレーターの使用
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
ES2683380T3 (es) 2012-06-08 2018-09-26 Sensorion Inhibidores del receptor H4 para tratar el tinnitus

Also Published As

Publication number Publication date
AP2002002401A0 (en) 2002-03-31
CN1486178A (zh) 2004-03-31
EE200300335A (et) 2003-12-15
OA12440A (en) 2006-05-22
DOP2002000325A (es) 2003-01-31
NO20033223D0 (no) 2003-07-16
CR6983A (es) 2003-11-25
SK8572003A3 (en) 2004-07-07
EP1353657A1 (en) 2003-10-22
CA2435121A1 (en) 2002-07-25
IS6818A (is) 2003-05-15
JP2004517883A (ja) 2004-06-17
ECSP034692A (es) 2003-08-29
PL362793A1 (en) 2004-11-02
GT200200003A (es) 2002-08-19
SV2003000849A (es) 2003-01-13
KR20030069216A (ko) 2003-08-25
BR0206502A (pt) 2003-10-21
WO2002056871A2 (en) 2002-07-25
HUP0302767A2 (hu) 2003-11-28
GB0101223D0 (en) 2001-02-28
EA200300537A1 (ru) 2004-02-26
TNSN02003A1 (fr) 2005-12-23
CZ20031853A3 (cs) 2004-07-14
ZA200304180B (en) 2004-06-15
AR032101A1 (es) 2003-10-22
NO20033223L (no) 2003-07-16
MA26980A1 (fr) 2004-12-20
IL156087A0 (en) 2003-12-23
BG107834A (bg) 2004-01-30
MXPA03006408A (es) 2003-10-15

Similar Documents

Publication Publication Date Title
PA8567001A1 (es) Composicion de ziprasidona y controles sinteticos
HN2002000299A (es) Derivados del 3- azabiciclo[3.1.0] hexano
DE69532162D1 (de) Cannabinoid-rezeptor-antagonisten
DK1379239T3 (da) N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
PA8527201A1 (es) Peptidos ciclados con actividad agonista para el receptor de la melanocortina-4 (mc4-r)
EE200300524A (et) Ühendid, mis on CB2-retseptori agonistid, neid sisaldavad ravimkoostised ja nimetatud ühendite kasutamine ravis
PT1328269E (pt) Associacao de um antagonista do receptor cb1 e de sibutramina composicoes farmaceuticas que os contem e sua utilizacao para o tratamento da obesidade
EE200300246A (et) EP4 retseptori suhtes selektiivsed agonistid osteoporoosi raviks
AR028505A1 (es) Utilizacion de un antagonista de los receptores de cannabinoides centrales para la preparacion de medicamentos utiles para que sea mas frcil detener el consumo de tabaco
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
PA8452701A1 (es) Agonistas de prostaglandinas
MXPA03010158A (es) Sulfonamidas.
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
UY28007A1 (es) Tratamiento terapeutico
PA8537101A1 (es) Antagonistas de receptores de histamina
YU39201A (sh) Upotreba 1-arilpirazola za pripremanje oralnog sredstva za suzbijanje parazita
UY26627A1 (es) Antagonistas de receptores de il-8
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
UY27124A1 (es) Antagonistas de receptores de histamina
NO20000518L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling